Failure of the gut barrier system enhances liver injury in rats: Protection of hepatocytes by gut-derived hepatocyte growth factor

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 10, 2004, Pages 1017-1025

  Choda, Yasuhiro ^a   Morimoto, Yoshinori ^a   Miyaso, Hideaki ^a   Shinoura, Susumu ^a   Saito, Shinya ^a   Yagi, Takahito ^a   Iwagaki, Hiromi ^a   Tanaka, Noriaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Fas ligand; Gut defence; Lipopolysaccharide; Toll like receptor

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD14 ANTIGEN; CD68 ANTIGEN; ENDOTOXIN; FAS LIGAND; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SCATTER FACTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL FLORA; BLOOD SAMPLING; CELL PROTECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER INJURY; NONHUMAN; OUTER MEMBRANE; PORTAL VEIN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; EPITHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MALE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 6944246195     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200410000-00011     Document Type: Article

References (51)

1. Raetz CR, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 1991; 5:2652-2660.
2. Suzuki S, Nakamura S, Serizawa A, Sakaguchi T, Konno H, Muro H, et al. Role of Kupffer cells and the spleen in modulation of endotoxin-induced liver injury after partial hepatectomy. Hepatology 1996; 24:219-225.
3. Enomoto N, Ikejima K, Bradford B, Rivera C, Kono H, Brenner DA, et al. Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology 1998; 115:443-451.
4. Whalan C, Drew P, Maddern G. Infection, sepsis and systemic inflammatory response syndrome in obstructive jaundice. J Gastroenterol Hepatol 1998; 13:354-355.
5. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995; 108:218-224.
6. Rush BF Jr, Sori AJ, Murphy TF, Smith S, Flanagan JJ Jr, Machiedo GW. Endotoxemia and bacteremia during hemorrhagic shock. The link between trauma and sepsis? Ann Surg 1998; 207:549-554.
7. Sedman PC, Macfie J, Sagar P, Mitchell CJ, May J, Mancey-Jones B, et al. The prevalence of gut translocation in humans. Gastroenterology 1994; 107:643-649.
8. Wells CL, Maddaus MA, Simmons RL. Proposed mechanism for the translocation of intestinal bacteria. Rev Infect Dis 1988; 10:958-979.
9. Sileri P, Sica GS, Rastellini C, Dicuonzo G, Gaspari AL, Cicalese L. Bacterial translocation and its surgical implications. G Chir 1999; 20:440-444.
10. Grotz MR, Deitch EA, Ding J, Xu D, Huang Q, Regel G. Intestinal cytokine response after gut ischemia: role of gut barrier failure. Ann Surg 1999; 229:478-486.
11. Mainous MR, Ertel W, Chaudry IH, Deitch EA. The gut: a cytokine-generating organ in systemic inflammation. Shock 1995; 4:193-199.
12. O'Neill LA, Dinarello CA. The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol Today 2000; 21:206-209.
13. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406:782-787.
14. Hemmi H, Takeuchi O, Kawai T, Kaisho S, Sato H, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-745.
15. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274:10689-10692.
16. DeWitt RC, Kudsk KA. The gut's role in metabolism, mucosal barrier function and gut immunology. Infect Dis Clin North Am 1999; 13: 465-481.
17. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors. J Immunol 2000; 164:966-972.
18. Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery 2002; 131:241-244.
19. Strain AJ, Ismail T, Tsubouchi H, Arakaki N, Hishida T, Kitamura N, et al. Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes. J Clin Invest 1991; 87:1853-1857.
20. Webber EM, Godowski PJ, Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994; 19:489-497.
21. Kaido T, Seto S, Yamaoka S, Yoshikawa A, Imamura M. Perioperative continuous hepatocyte growth factor supply prevents postoperative liver failure in rats with liver cirrhosis. J Surg Res 1998; 74:173-178.
22. Deitch EA, Morrison J, Berg R, Specian RD. Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats. Crit Care Med 1990; 18:529-536.
23. Benoit R, Rowe S, Watkins SC, Boyle P, Garrett M, Alber S, et al. Pure endotoxin does not pass across the intestinal epithelium in vitro. Shock 1998; 10:43-48.
24. Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001; 34:101-108.
25. Bjarnason I, Peters TJ, Wise RJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984; i:179-182.
26. Bode JC, Bode C, Heidelbach R, Durr HK, Martini GA. Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology 1984; 31:30-34.
27. Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, et al. IL-18 accounts for both TNF-alpha and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 1997; 159:3961-3967.
28. Fujioka N, Mukaida N, Harada A, Akiyama M, Kasahara T, Kuno K, et al. Preparation of specific antibodies against murine IL-1 ra and the establishment of IL-1 ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J Leukoc Biol 1995; 58:90-98.
29. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378:88-91.
30. Nicoletti F, Di Marco R, Zaccone P, Salvaggio A, Magro G, Bendtzen K, et al. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism. Hepatology 2000; 32: 728-733.
31. Michalopoulos GK, DeFrances MG. Liver regeneration. Science 1997; 276:60-66.
32. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122:1450-1459.
33. Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S, et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 1990; 173:42-47.
34. Zarnegar R, DeFrances MG, Kost DP, Lindroos P, Michalopoulos GK. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun 1991; 177:559-565.
35. Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 1991; 6:501-504.
36. Xian CJ, Couper R, Howarth GS, Read LC, Kallincos NC. Increased expression of HGF and c-met in rat small intestine during recovery from methotrexate-induced mucositis. Br J Cancer 2000; 82:945-952.
37. Kosai K, Matsumoto K, Funakoshi H, Nakamura T. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 1999; 30:151-159.
38. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 1990; 11:443-449.
39. Ulich T, Yin S, Guo K, Yi E, Remick D, del Castillo J. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol 1991; 138:1097-1101.
40. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994; 179: 1529-1537.
41. Camargo CA Jr, Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26:1513-1520.
42. Clavien PA, Camargo CA Jr, Gorczynski R, Washington MK, Levy GA, Langer B, et al. Acute reactant cytokines and neutrophil adhesion after following warm ischemia in cirrhotic and noncirrhotic human livers. Hepatology 1996; 23:1456-1463.
43. Solomon KR, Kurt-Jones EA, Saladino RA, Stack AM, Dunn IF, Ferretti M, et al. Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharide. J Clin Invest 1998; 102:2019-2027.
44. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388:394-397.
45. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189:615-625.
46. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999; 96:14459-14463.
47. Matsuguchi T, Musikacharoen T, Ogawa T, Yoshikai Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 2000; 165:5767-5772.
48. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of the Fas ligand in the development of hepatitis. Nat Med 1997; 3: 409-413.
49. Muschen M, Warskulat U, Peters-Regehr T, Bode JG, Kubitz R, Haussinger D. Involvement of CD95(Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation. Gastroenterology 1999; 116:666-677.
50. Sun Z, Wada T, Uchikura K, Ceppa E, Klein AS. Role of Fas/FasL in Kupffer cell-dependent deletion of alloantigen activated T cells following liver transplantation. Transplant Proc 2001; 33:279-282.
51. Squiers EC, Brunson ME, Salomon DR. Kupffer cells can present alloantigen in vitro: an effect abrogated by gadolinium. J Surg Res 1993: 55:571-574.